{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:32:31Z","timestamp":1788561151850,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>In December 2014, a multinational collaboration of hemovigilance experts from the International Society of Blood Transfusion (ISBT), the International Hemovigilance Network, and AABB published harmonized definitions of complications related to blood donation titled \u201cStandard for Surveillance of Complications Related to Blood Donation.\u201d Both mandatory and optional terms were included. The definitions are endorsed by the Alliance of Blood Operators and the European Blood Alliance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN AND METHODS<\/jats:title>\n                    <jats:p>The objective of this study was to validate harmonized donor hemovigilance definitions with potential users. In June 2016, 30 real\u2010world cases were sent to potential users around the world along with the definitions, an answer sheet, and instructions on how to complete the validation exercise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Overall, 54 responses from 25 countries were received, including over 400 comments. The results were presented for feedback at both ISBT and AABB meetings. Case diagnoses were consistent across most responders. Exceptions were rare adverse events, nonstandard presentations, or incomplete information. In general, the application of optional definitions, including severity grading and imputability, had the most variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The use of standardized terms in the donor setting serves to increase focus on donor safety, facilitate conversation, foster exchange of information, and frame questions for future research. Overall, the definitions provide adequate coverage of donor reactions; however, some terms require clarification. Severity grading and imputability and other optional terms need clear and objective definitions and instructions on when and how to use them. Additional feedback and final recommendations are summarized in this report.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.14948","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T03:59:37Z","timestamp":1538971177000},"page":"2589-2595","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["International validation of harmonized definitions for complications of blood donations"],"prefix":"10.1111","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-1617","authenticated-orcid":false,"given":"Kevin J.","family":"Land","sequence":"first","affiliation":[{"name":"Blood Systems, Inc.  San Antonio Texas"},{"name":"UT Health Science Center at San Antonio, Department of Pathology  San Antonio Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Townsend","sequence":"additional","affiliation":[{"name":"Blood Systems, Inc.  San Antonio Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Goldman","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbee I.","family":"Whitaker","sequence":"additional","affiliation":[{"name":"AABB  Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela E.","family":"Perez","sequence":"additional","affiliation":[{"name":"AABB  Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3451-9911","authenticated-orcid":false,"given":"Jo C.","family":"Wiersum\u2010Osselton","sequence":"additional","affiliation":[{"name":"TRIP Hemovigilance and Biovigilance  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"National hemovigilance: the current state","author":"Land KJ","year":"2018"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01442.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13957"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2011.12.003"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1423-0410.2007.01000.x","article-title":"Complications related to blood donation: a population\u2010based study","volume":"94","author":"Sorensen BS","year":"2007","journal-title":"Vox Sang"},{"key":"e_1_2_8_7_1","unstructured":"RajbhandaryS StubbsJR LandKJ et al. editors.AABB donor hemovigilance report: 2012\u20132014 on behalf of the AABB US Donor Hemovigilance Working Group. 2016 [cited 2018 Apr 4]. Available from:http:\/\/www.aabb.org\/research\/hemovigilance\/documents\/2012-2014-AABB-Donor-Hemovigilance-Report.pdf."},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0787-y"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02574.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02057.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03143.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13716"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12275"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12011"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01494.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12323"},{"key":"e_1_2_8_17_1","unstructured":"ISBT website [cited 2018 Mar 16]. Available fromhttp:\/\/www.isbtweb.org\/working-parties\/haemovigilance\/(click on definitions)."},{"key":"e_1_2_8_18_1","unstructured":"Working Group on Donor Vigilance of the International Society of Blood Transfusion Working Party on Haemovigilance The International Haemovigilance Network The AABB Donor Haemovigilance Working Group. Standard for surveillance of complications related to blood donation. December 11 2014 [cited 2018 Apr 4]. Available from:http:\/\/www.aabb.org\/research\/hemovigilance\/Documents\/Donor-Standard-Definitions.pdf."},{"key":"e_1_2_8_19_1","unstructured":"Public Health Service Biovigilance Task Group Biovigilance in the United States: efforts to bridge a critical gap in patient safety and donor health. Washington (DC): HHS; 2009 [cited 2018 Apr 6]. Available from:https:\/\/wayback.archive-it.org\/3922\/20140403203201\/http:\/\/www.hhs.gov\/ash\/bloodsafety\/biovigilance\/ash_to_acbsa_oct_2009.pdf."},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0269888900007797"},{"key":"e_1_2_8_21_1","unstructured":"OED Online. January 2018 [cited 2018 Apr 6]. Oxford University Press. Available from:https:\/\/en.oxforddictionaries.com\/definition\/ontology."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2012.01659.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12620"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.14948","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14948","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.14948","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T11:02:59Z","timestamp":1772967779000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.14948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/trf.14948"],"URL":"https:\/\/doi.org\/10.1111\/trf.14948","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"2018-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}